Condition Monitoring for Pharmaceutical

Direct experience at Reliability Consulting for Pharmaceutical Manufacturing sites is non-negotiable. Generic industrial Condition Monitoring skills don't transfer cleanly to Reliability Consulting for Pharmaceutical Manufacturing because of GMP validation, cleanroom equipment, batch traceability and the regulatory layer (FDA cGMP, EU Annex 15, ICH Q7). Ask for the lead analyst's hours of Reliability Consulting for Pharmaceutical Manufacturing-specific work, certifications relevant to ISO 17359 and ISO 13374, and references from comparable plants in the same industry segment. Vendor-provided references screen positive almost universally — call them directly.

monthly on critical, quarterly on B-criticality as the starting baseline. Reliability Consulting for Pharmaceutical Manufacturing environments often justify tighter intervals on a subset of assets — specifically those most exposed to sanitary pump reliability, clean utility integrity, batch traceability. The Condition Monitoring program scope at most Reliability Consulting for Pharmaceutical Manufacturing sites we work with covers 30 to 80 critical assets in detail with broader screening on the supporting equipment. Cost works out to $180-$300 per asset per month for the detailed assets.

Pharmaceutical sites typically operate under FDA cGMP, EU Annex 15, ICH Q7. For Condition Monitoring programs that translates into documentation requirements: traceable measurement records, calibrated instruments with audit certificates, written procedures aligned to ISO 17359 and ISO 13374. The technical work is the same as any other industrial site, but the paper trail behind it is heavier. Plants new to regulated environments usually underestimate the documentation overhead by 20 to 30 percent.

Direct experience at Pharmaceutical sites is non-negotiable. Generic industrial Condition Monitoring skills don't transfer cleanly to Pharmaceutical because of GMP validation, cleanroom equipment, batch traceability and the regulatory layer (FDA cGMP, EU Annex 15, ICH Q7). Ask for the lead analyst's hours of Pharmaceutical-specific work, certifications relevant to ISO 17359 and ISO 13374, and references from comparable plants in the same industry segment. Vendor-provided references screen positive almost universally — call them directly.